Treatment and Outcomes of DLBCL After Progression on Polatuzumab Vedotin-based Combination Therapy
Peking Union Medical College Hospital
Peking Union Medical College Hospital
Academic and Community Cancer Research United
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Nanfang Hospital, Southern Medical University
University of Minnesota